Literature DB >> 2338501

Development of a new culture system for human lymphokine-activated killer cells.

M Murata1, T Yano, M Togami, K Yasumoto, K Sugimachi, G Kimura, K Nomoto.   

Abstract

We have developed a new culture system (termed the JCC device) for the generation and expansion of human lymphokine-activated killer (LAK) cells. The JCC device was essentially based on dialysis culture. A dialysis membrane divided the culture vessel from the outside circulation of basal medium. Human lymph node lymphocytes were cultured in the culture vessel using a culture volume of 100 ml at an initial cell density of 1 X 10(6)/ml in the presence of recombinant human interleukin-2. The culture vessel was rotated for the proper dispersion of cells. The cell density reached up to 1.2 X 10(7)/ml on day 17 of culture. A modified JCC device supplying oxygen through a silicon tube prevented oxygen depletion in the culture vessel. With this modified JCC device cell densities up to 4.3 X 10(7)/ml were achieved without reduction of cytolytic activity. Cell viability was more than 90% throughout the culture. The use of this JCC device permitted the culturing of LAK cells at a high cell density. The procedure is relatively cheap, simple and less time consuming than previous methods.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2338501     DOI: 10.1016/0022-1759(90)90424-t

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  2 in total

1.  A new culture system for the cultivation of mammalian cells for the production of several biologically active substances.

Authors:  M Murata; M Togami; Y Tawara; K Onodera
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

2.  Development of a new culture system for human lymphokine-activated killer cells: comparison with a conventional static culture method.

Authors:  M Murata; T Yano; I Yoshino; M Togami; M Sogabe; K Yasumoto; K Sugimachi; G Kimura; K Nomoto
Journal:  Cytotechnology       Date:  1991-10       Impact factor: 2.058

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.